Risk factors, histopathology and diagnostic accuracy in posterior placenta accreta spectrum disorders: systematic review and meta-analysis
- PMID: 32840934
- DOI: 10.1002/uog.22183
Risk factors, histopathology and diagnostic accuracy in posterior placenta accreta spectrum disorders: systematic review and meta-analysis
Abstract
Objective: To elucidate the risk factors, histopathological correlations and diagnostic accuracy of prenatal imaging in pregnancies complicated by posterior placenta accreta spectrum (PAS) disorders.
Methods: MEDLINE, EMBASE and CINAHL were searched for studies reporting on women with posterior PAS. Inclusion criteria were women with posterior PAS confirmed either at surgery or on histopathological analysis. The outcomes explored were risk factors for posterior PAS, histopathological correlation and the diagnostic accuracy of ultrasound and magnetic resonance imaging (MRI) in detecting posterior PAS. Random-effects meta-analysis of proportions was used to analyze the data.
Results: Twenty studies were included. Placenta previa was present in 92.8% (107/114; 17 studies) of pregnancies complicated by posterior PAS, while 76.1% (53/88; 11 studies) of women had had prior uterine surgery, mainly a Cesarean section (CS) or curettage and 82.5% (66/77; 10 studies) were multiparous. When considering histopathological analysis in women affected by posterior PAS, 77.5% (34/44; 11 studies) had placenta accreta, 19.5% (8/44; 11 studies) had placenta increta and 9.3% (2/44; 11 studies) had placenta percreta. Of the cases of posterior PAS disorder, 52.4% (31/63; 12 studies) were detected prenatally on ultrasound, while 46.7% (32/63; 12 studies) were diagnosed only at birth. When exploring the distribution of the classic ultrasound signs of PAS, placental lacunae were present in 39.0% (12/30; seven studies), loss of the clear zone in 41.1% (13/30; seven studies) and bladder-wall interruption in 16.6% (4/30; seven studies) of women, while none of the included cases showed hypervascularization at the bladder-wall interface. When assessing the role of MRI in detecting posterior PAS, 73.5% (26/32; 11 studies) of cases were detected on prenatal MRI, while 26.5% (6/32; 11 studies) were discovered only at the time of CS.
Conclusions: Placenta previa, prior uterine surgery and multiparity represent the most commonly reported risk factors for posterior PAS. Ultrasound had a very low diagnostic accuracy in detecting these disorders prenatally. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.
Keywords: MRI; outcome; placenta accreta spectrum; posterior placenta; prenatal diagnosis; ultrasound.
© 2020 International Society of Ultrasound in Obstetrics and Gynecology.
Similar articles
-
Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.Ultrasound Obstet Gynecol. 2022 Apr;59(4):474-482. doi: 10.1002/uog.23732. Epub 2022 Mar 8. Ultrasound Obstet Gynecol. 2022. PMID: 34225385 Free PMC article.
-
Risk factors, prenatal diagnosis, and outcome of posterior placenta accreta spectrum disorders in patients with placenta previa or low-lying placenta: A multicenter study.Acta Obstet Gynecol Scand. 2025 Jul;104(7):1328-1338. doi: 10.1111/aogs.15132. Epub 2025 May 19. Acta Obstet Gynecol Scand. 2025. PMID: 40387324 Free PMC article.
-
Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.Ultrasound Obstet Gynecol. 2022 Sep;60(3):381-389. doi: 10.1002/uog.24889. Ultrasound Obstet Gynecol. 2022. PMID: 35247287 Free PMC article.
-
Systematic review and meta-analysis on placenta accreta spectrum disorders in twin pregnancies: risk factors, detection rate and histopathology.Minerva Obstet Gynecol. 2023 Feb;75(1):55-61. doi: 10.23736/S2724-606X.21.04886-7. Epub 2021 Jul 30. Minerva Obstet Gynecol. 2023. PMID: 34328297
-
Systematic review on near miss cases of placenta accreta spectrum disorders: correlation with invasion topography, prenatal imaging, and surgical outcome.J Matern Fetal Neonatal Med. 2020 Oct;33(19):3377-3384. doi: 10.1080/14767058.2019.1570494. Epub 2019 Jan 30. J Matern Fetal Neonatal Med. 2020. PMID: 30700221
Cited by
-
Placenta accreta spectrum-a catastrophic situation in obstetrics.Obstet Gynecol Sci. 2021 May;64(3):239-247. doi: 10.5468/ogs.20345. Epub 2021 Mar 24. Obstet Gynecol Sci. 2021. PMID: 33757280 Free PMC article.
-
Quality of surgical management of placenta accreta spectrum in a tertiary center in Sri Lanka: baseline study for quality improvement project: problems and solutions.BMC Pregnancy Childbirth. 2022 Jun 23;22(1):509. doi: 10.1186/s12884-022-04840-7. BMC Pregnancy Childbirth. 2022. PMID: 35739493 Free PMC article.
-
Radiomic study of antenatal prediction of severe placenta accreta spectrum from MRI.Br J Radiol. 2024 Nov 1;97(1163):1833-1842. doi: 10.1093/bjr/tqae164. Br J Radiol. 2024. PMID: 39152998 Free PMC article.
-
Risk factors for postpartum haemorrhage in women with histologically verified placenta accreta spectrum disorders: a retrospective single-centre cross-sectional study.BMC Pregnancy Childbirth. 2023 Nov 11;23(1):786. doi: 10.1186/s12884-023-06103-5. BMC Pregnancy Childbirth. 2023. PMID: 37951863 Free PMC article.
-
Incidence, risk factors and maternal outcomes of unsuspected placenta accreta spectrum disorders: a retrospective cohort study.BMC Pregnancy Childbirth. 2024 Jan 23;24(1):76. doi: 10.1186/s12884-024-06254-z. BMC Pregnancy Childbirth. 2024. PMID: 38262978 Free PMC article.
References
REFERENCES
-
- Cali G, Forlani F, Lees C, Timor-Tritsch I, Palacios-Jaraquemada J, Dall'Asta A, Bhide A, Flacco ME, Manzoli L, Labate F, Perino A, Scambia G, D'Antonio F. Prenatal ultrasound staging system for placenta accreta spectrum disorders. Ultrasound Obstet Gynecol 2019; 53: 752-760.
-
- Belfort MA. Placenta accreta. Am J Obstet Gynecol 2010; 203: 430-439.
-
- Iacovelli A, Liberati M, Khalil A, Timor-Trisch I, Leombroni M, Buca D, Milani M, Flacco ME, Manzoli L, Fanfani F, Calì G, Familiari A, Scambia G, D'Antonio F. Risk factors for abnormally invasive placenta: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2020; 33: 471-481.
-
- Silver RM, Fox KA, Barton JR, Abuhamad AZ, Simhan H, Huls CK, Belfort MA, Wright JD. Center of excellence for placenta accreta. Am J Obstet Gynecol 2015; 212: 561-568.
-
- Buca D, Liberati M, Calì G, Forlani F, Caisutti C, Flacco ME, Manzoli L, Familiari A, Scambia G, D'Antonio F. Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018; 52: 304-309.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical